Comprehensive Periodontal Disease Treatment = SRP +Antibiotic

Scaling and Root Planing (SRP): The Foundation of Treatment

Why isn't scaling and root planing (SRP) enough to eliminate persistent periodontal infections?

Even after the very best professional SRP, the red complex bacteria responsible for the active infection and inflammation remain, multiply, and can return to baseline levels within days.

Use of scaling instruments is limited in areas of restricted access and cannot eliminate periodontal bacteria.

As with many active infections, periodontitis should be treated with an antibiotic, like ARESTIN®.

Limitations of SRP

No matter how expert our technique, the instruments we use during SRP cannot reach all the tooth surfaces that harbor bacteria, due to:

  • Furcations
  • Root flutings
  • Adjacent teeth in close proximity
  • Microscopic irregularities in tooth surfaces - especially at cementoenamal junctions
  • Restorations
Image of periodontitis bacteria

Areas of restricted access create reservoirs for bacteria and residual biofilm left behind after scaling

What about lasers?

Soft tissue lasers have applications - and benefits:

  • Delivery of multiple, minimally invasive soft tissue procedures for oral surgery, tissue fusion, implant exposure, and incisions
  • Improved coagulation leading to better visualization of the surgical field
  • Sulcular debridement/curettage to remove infected soft tissue in the periodontal pocket

But there is insufficient evidence that lasers result in greater reductions of subgingival bacteria vs traditional mechanical treatments:

Summary of effects of various laser wavelengths vs. SPR on
subgingival bacteria

Microbiological limitations of periodontal laser surgery include:

  • Requirement of a direct hit by the energy beam to remove bacteria is made difficult by hard-to-access areas and anatomical limitations
  • The density, thickness, and protective matrix of subgingival biofilm
  • Persistence of subgingival bacteria following laser procedures (As with other mechanical therapies, bacteria remain, multiply, and can return to baseline levels within days)

ARESTIN® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

IMPORTANT SAFETY INFORMATION

ARESTIN® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face and pruritus have been reported with the use of ARESTIN®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome and pain.

Please see Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contact us with questions about your account or MyArestin.com